LivaNova PLC Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent
LivaNova PLC (LIVN) had Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent of $0 as of 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent · last filed 2019-03-18
- 2018-12-31: Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent $0.00.
- 2018-03-31: Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent $0.00.
- 2017-12-31: Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent $1.28M.
- 2017-09-30: Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent $1.96M.
| Period end | Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-18 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-03 |
| 2017-12-31 | $1.28M 10-K · filed 2019-03-18 |
| 2017-09-30 | $1.96M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $1.93M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $7.42M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $2.03M 10-K · filed 2018-02-28 |
| 2015-12-31 | $2.21M 10-K · filed 2017-03-01 |
| 2015-04-24 | $0.00 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |